Here are five things to know about the downgrade:
1. Stryker’s shares currently have an “underweight” rating, down from “equal weight.”
2. Price target for the shares went from $88 to $92 per share.
3. Stryker stock price is expected to reach $99.79 in the short term.
4. There are 14 analysts agreeing with the consensus, with a higher short term estimate at $105 and lower at $88.
5. The market cap is $34.7 billion with 378.9 million shares outstanding.
Stryker shares did drop 1.56 percent over the past week but the big picture remains bullish, according to the report, and shares posted positive gains of 1.17 percent over the last four weeks.
More articles on orthopedic devices:
12 observations on implant materials for the next generation
16 spine devices receive FDA 510(k) clearance in March
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
